nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—ALB—Auranofin—psoriatic arthritis	0.372	0.521	CbGbCtD
Gliclazide—ALB—Prednisone—psoriatic arthritis	0.118	0.166	CbGbCtD
Gliclazide—CYP2C19—Prednisone—psoriatic arthritis	0.0767	0.107	CbGbCtD
Gliclazide—ALB—Methotrexate—psoriatic arthritis	0.0593	0.0831	CbGbCtD
Gliclazide—CYP2C19—Dexamethasone—psoriatic arthritis	0.0479	0.0671	CbGbCtD
Gliclazide—CYP2C9—Dexamethasone—psoriatic arthritis	0.0398	0.0558	CbGbCtD
Gliclazide—VEGFA—Dexamethasone—Methylprednisolone—psoriatic arthritis	0.000946	0.105	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Methylprednisolone—psoriatic arthritis	0.000946	0.105	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Dexamethasone—psoriatic arthritis	0.000931	0.104	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Betamethasone—psoriatic arthritis	0.000931	0.104	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Triamcinolone—psoriatic arthritis	0.000909	0.101	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Triamcinolone—psoriatic arthritis	0.000909	0.101	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Prednisone—psoriatic arthritis	0.000863	0.0961	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Prednisone—psoriatic arthritis	0.000863	0.0961	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Prednisolone—psoriatic arthritis	0.000843	0.0938	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Prednisolone—psoriatic arthritis	0.000843	0.0938	CbGdCrCtD
Gliclazide—Hypertension—Triamcinolone—psoriatic arthritis	0.000366	0.00132	CcSEcCtD
Gliclazide—Hypertension—Methylprednisolone—psoriatic arthritis	0.000365	0.00131	CcSEcCtD
Gliclazide—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000363	0.00131	CcSEcCtD
Gliclazide—Myalgia—Triamcinolone—psoriatic arthritis	0.000361	0.0013	CcSEcCtD
Gliclazide—Pneumonia—Methotrexate—psoriatic arthritis	0.00036	0.0013	CcSEcCtD
Gliclazide—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00036	0.0013	CcSEcCtD
Gliclazide—Myalgia—Methylprednisolone—psoriatic arthritis	0.00036	0.0013	CcSEcCtD
Gliclazide—Eye disorder—Prednisone—psoriatic arthritis	0.000359	0.00129	CcSEcCtD
Gliclazide—Anxiety—Methylprednisolone—psoriatic arthritis	0.000359	0.00129	CcSEcCtD
Gliclazide—Drowsiness—Methotrexate—psoriatic arthritis	0.000358	0.00129	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000357	0.00129	CcSEcCtD
Gliclazide—Depression—Methotrexate—psoriatic arthritis	0.000357	0.00129	CcSEcCtD
Gliclazide—Flushing—Prednisone—psoriatic arthritis	0.000357	0.00129	CcSEcCtD
Gliclazide—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000357	0.00129	CcSEcCtD
Gliclazide—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000357	0.00129	CcSEcCtD
Gliclazide—Discomfort—Triamcinolone—psoriatic arthritis	0.000356	0.00128	CcSEcCtD
Gliclazide—Discomfort—Methylprednisolone—psoriatic arthritis	0.000356	0.00128	CcSEcCtD
Gliclazide—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000355	0.00128	CcSEcCtD
Gliclazide—Dry mouth—Triamcinolone—psoriatic arthritis	0.000353	0.00127	CcSEcCtD
Gliclazide—Renal failure—Methotrexate—psoriatic arthritis	0.000352	0.00127	CcSEcCtD
Gliclazide—Angioedema—Dexamethasone—psoriatic arthritis	0.000351	0.00127	CcSEcCtD
Gliclazide—Angioedema—Betamethasone—psoriatic arthritis	0.000351	0.00127	CcSEcCtD
Gliclazide—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000348	0.00125	CcSEcCtD
Gliclazide—Confusional state—Methylprednisolone—psoriatic arthritis	0.000348	0.00125	CcSEcCtD
Gliclazide—Malaise—Dexamethasone—psoriatic arthritis	0.000347	0.00125	CcSEcCtD
Gliclazide—Malaise—Betamethasone—psoriatic arthritis	0.000347	0.00125	CcSEcCtD
Gliclazide—Arrhythmia—Prednisone—psoriatic arthritis	0.000343	0.00124	CcSEcCtD
Gliclazide—Infection—Triamcinolone—psoriatic arthritis	0.000343	0.00124	CcSEcCtD
Gliclazide—Sweating—Methotrexate—psoriatic arthritis	0.000343	0.00124	CcSEcCtD
Gliclazide—Infection—Methylprednisolone—psoriatic arthritis	0.000343	0.00123	CcSEcCtD
Gliclazide—Insomnia—Prednisolone—psoriatic arthritis	0.00034	0.00123	CcSEcCtD
Gliclazide—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000339	0.00122	CcSEcCtD
Gliclazide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000338	0.00122	CcSEcCtD
Gliclazide—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000338	0.00122	CcSEcCtD
Gliclazide—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000338	0.00122	CcSEcCtD
Gliclazide—Epistaxis—Methotrexate—psoriatic arthritis	0.000338	0.00122	CcSEcCtD
Gliclazide—Paraesthesia—Prednisolone—psoriatic arthritis	0.000338	0.00122	CcSEcCtD
Gliclazide—Tachycardia—Triamcinolone—psoriatic arthritis	0.000337	0.00122	CcSEcCtD
Gliclazide—Mental disorder—Prednisone—psoriatic arthritis	0.000337	0.00121	CcSEcCtD
Gliclazide—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000337	0.00121	CcSEcCtD
Gliclazide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000335	0.00121	CcSEcCtD
Gliclazide—Malnutrition—Prednisone—psoriatic arthritis	0.000335	0.00121	CcSEcCtD
Gliclazide—Erythema—Prednisone—psoriatic arthritis	0.000335	0.00121	CcSEcCtD
Gliclazide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000334	0.0012	CcSEcCtD
Gliclazide—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000334	0.0012	CcSEcCtD
Gliclazide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000333	0.0012	CcSEcCtD
Gliclazide—Convulsion—Dexamethasone—psoriatic arthritis	0.000333	0.0012	CcSEcCtD
Gliclazide—Convulsion—Betamethasone—psoriatic arthritis	0.000333	0.0012	CcSEcCtD
Gliclazide—Hypertension—Dexamethasone—psoriatic arthritis	0.000332	0.0012	CcSEcCtD
Gliclazide—Hypertension—Betamethasone—psoriatic arthritis	0.000332	0.0012	CcSEcCtD
Gliclazide—Myalgia—Dexamethasone—psoriatic arthritis	0.000327	0.00118	CcSEcCtD
Gliclazide—Myalgia—Betamethasone—psoriatic arthritis	0.000327	0.00118	CcSEcCtD
Gliclazide—Anxiety—Dexamethasone—psoriatic arthritis	0.000326	0.00118	CcSEcCtD
Gliclazide—Anxiety—Betamethasone—psoriatic arthritis	0.000326	0.00118	CcSEcCtD
Gliclazide—Discomfort—Dexamethasone—psoriatic arthritis	0.000323	0.00116	CcSEcCtD
Gliclazide—Discomfort—Betamethasone—psoriatic arthritis	0.000323	0.00116	CcSEcCtD
Gliclazide—Hypotension—Methylprednisolone—psoriatic arthritis	0.000322	0.00116	CcSEcCtD
Gliclazide—Pain—Prednisolone—psoriatic arthritis	0.000321	0.00116	CcSEcCtD
Gliclazide—Hepatitis—Methotrexate—psoriatic arthritis	0.000321	0.00116	CcSEcCtD
Gliclazide—Pharyngitis—Methotrexate—psoriatic arthritis	0.000319	0.00115	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000315	0.00113	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000314	0.00113	CcSEcCtD
Gliclazide—Insomnia—Triamcinolone—psoriatic arthritis	0.000313	0.00113	CcSEcCtD
Gliclazide—Insomnia—Methylprednisolone—psoriatic arthritis	0.000312	0.00112	CcSEcCtD
Gliclazide—Infection—Betamethasone—psoriatic arthritis	0.000312	0.00112	CcSEcCtD
Gliclazide—Infection—Dexamethasone—psoriatic arthritis	0.000312	0.00112	CcSEcCtD
Gliclazide—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000311	0.00112	CcSEcCtD
Gliclazide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00031	0.00112	CcSEcCtD
Gliclazide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00031	0.00112	CcSEcCtD
Gliclazide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00031	0.00112	CcSEcCtD
Gliclazide—Visual impairment—Methotrexate—psoriatic arthritis	0.00031	0.00112	CcSEcCtD
Gliclazide—Anaemia—Prednisone—psoriatic arthritis	0.000309	0.00111	CcSEcCtD
Gliclazide—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000308	0.00111	CcSEcCtD
Gliclazide—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000308	0.00111	CcSEcCtD
Gliclazide—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000308	0.00111	CcSEcCtD
Gliclazide—Agitation—Prednisone—psoriatic arthritis	0.000308	0.00111	CcSEcCtD
Gliclazide—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000307	0.00111	CcSEcCtD
Gliclazide—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000307	0.00111	CcSEcCtD
Gliclazide—Tachycardia—Dexamethasone—psoriatic arthritis	0.000306	0.0011	CcSEcCtD
Gliclazide—Tachycardia—Betamethasone—psoriatic arthritis	0.000306	0.0011	CcSEcCtD
Gliclazide—Angioedema—Prednisone—psoriatic arthritis	0.000306	0.0011	CcSEcCtD
Gliclazide—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000304	0.0011	CcSEcCtD
Gliclazide—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000304	0.00109	CcSEcCtD
Gliclazide—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000304	0.00109	CcSEcCtD
Gliclazide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000303	0.00109	CcSEcCtD
Gliclazide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000303	0.00109	CcSEcCtD
Gliclazide—Malaise—Prednisone—psoriatic arthritis	0.000302	0.00109	CcSEcCtD
Gliclazide—Eye disorder—Methotrexate—psoriatic arthritis	0.0003	0.00108	CcSEcCtD
Gliclazide—Tinnitus—Methotrexate—psoriatic arthritis	0.0003	0.00108	CcSEcCtD
Gliclazide—Urticaria—Prednisolone—psoriatic arthritis	0.000299	0.00108	CcSEcCtD
Gliclazide—Fatigue—Triamcinolone—psoriatic arthritis	0.000298	0.00107	CcSEcCtD
Gliclazide—Fatigue—Methylprednisolone—psoriatic arthritis	0.000297	0.00107	CcSEcCtD
Gliclazide—Pain—Triamcinolone—psoriatic arthritis	0.000296	0.00107	CcSEcCtD
Gliclazide—Loss of consciousness—Prednisone—psoriatic arthritis	0.000294	0.00106	CcSEcCtD
Gliclazide—Hypotension—Dexamethasone—psoriatic arthritis	0.000293	0.00106	CcSEcCtD
Gliclazide—Hypotension—Betamethasone—psoriatic arthritis	0.000293	0.00106	CcSEcCtD
Gliclazide—Convulsion—Prednisone—psoriatic arthritis	0.00029	0.00105	CcSEcCtD
Gliclazide—Hypertension—Prednisone—psoriatic arthritis	0.000289	0.00104	CcSEcCtD
Gliclazide—Chills—Methotrexate—psoriatic arthritis	0.000288	0.00104	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000286	0.00103	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000286	0.00103	CcSEcCtD
Gliclazide—Arthralgia—Prednisone—psoriatic arthritis	0.000285	0.00103	CcSEcCtD
Gliclazide—Myalgia—Prednisone—psoriatic arthritis	0.000285	0.00103	CcSEcCtD
Gliclazide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000285	0.00103	CcSEcCtD
Gliclazide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000284	0.00102	CcSEcCtD
Gliclazide—Anxiety—Prednisone—psoriatic arthritis	0.000284	0.00102	CcSEcCtD
Gliclazide—Insomnia—Betamethasone—psoriatic arthritis	0.000284	0.00102	CcSEcCtD
Gliclazide—Insomnia—Dexamethasone—psoriatic arthritis	0.000284	0.00102	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000283	0.00102	CcSEcCtD
Gliclazide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000282	0.00102	CcSEcCtD
Gliclazide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000282	0.00101	CcSEcCtD
Gliclazide—Paraesthesia—Betamethasone—psoriatic arthritis	0.000282	0.00101	CcSEcCtD
Gliclazide—Discomfort—Prednisone—psoriatic arthritis	0.000282	0.00101	CcSEcCtD
Gliclazide—Mental disorder—Methotrexate—psoriatic arthritis	0.000282	0.00101	CcSEcCtD
Gliclazide—Erythema—Methotrexate—psoriatic arthritis	0.00028	0.00101	CcSEcCtD
Gliclazide—Malnutrition—Methotrexate—psoriatic arthritis	0.00028	0.00101	CcSEcCtD
Gliclazide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000277	0.000998	CcSEcCtD
Gliclazide—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000276	0.000995	CcSEcCtD
Gliclazide—Dyspepsia—Betamethasone—psoriatic arthritis	0.000276	0.000995	CcSEcCtD
Gliclazide—Urticaria—Triamcinolone—psoriatic arthritis	0.000275	0.00099	CcSEcCtD
Gliclazide—Urticaria—Methylprednisolone—psoriatic arthritis	0.000274	0.000987	CcSEcCtD
Gliclazide—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000273	0.000985	CcSEcCtD
Gliclazide—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000273	0.000983	CcSEcCtD
Gliclazide—Infection—Prednisone—psoriatic arthritis	0.000271	0.000978	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000271	0.000976	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000271	0.000976	CcSEcCtD
Gliclazide—Back pain—Methotrexate—psoriatic arthritis	0.000271	0.000975	CcSEcCtD
Gliclazide—Fatigue—Betamethasone—psoriatic arthritis	0.00027	0.000975	CcSEcCtD
Gliclazide—Fatigue—Dexamethasone—psoriatic arthritis	0.00027	0.000975	CcSEcCtD
Gliclazide—Pain—Dexamethasone—psoriatic arthritis	0.000268	0.000967	CcSEcCtD
Gliclazide—Pain—Betamethasone—psoriatic arthritis	0.000268	0.000967	CcSEcCtD
Gliclazide—Nervous system disorder—Prednisone—psoriatic arthritis	0.000268	0.000965	CcSEcCtD
Gliclazide—Tachycardia—Prednisone—psoriatic arthritis	0.000267	0.000961	CcSEcCtD
Gliclazide—Skin disorder—Prednisone—psoriatic arthritis	0.000265	0.000956	CcSEcCtD
Gliclazide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000264	0.000952	CcSEcCtD
Gliclazide—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00026	0.000935	CcSEcCtD
Gliclazide—Anaemia—Methotrexate—psoriatic arthritis	0.000259	0.000932	CcSEcCtD
Gliclazide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000258	0.000931	CcSEcCtD
Gliclazide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000258	0.000931	CcSEcCtD
Gliclazide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000256	0.000924	CcSEcCtD
Gliclazide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000256	0.000924	CcSEcCtD
Gliclazide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000255	0.000918	CcSEcCtD
Gliclazide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000254	0.000916	CcSEcCtD
Gliclazide—Malaise—Methotrexate—psoriatic arthritis	0.000252	0.000909	CcSEcCtD
Gliclazide—Leukopenia—Methotrexate—psoriatic arthritis	0.00025	0.000902	CcSEcCtD
Gliclazide—Urticaria—Dexamethasone—psoriatic arthritis	0.000249	0.000898	CcSEcCtD
Gliclazide—Urticaria—Betamethasone—psoriatic arthritis	0.000249	0.000898	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000249	0.000897	CcSEcCtD
Gliclazide—Dizziness—Prednisolone—psoriatic arthritis	0.000249	0.000896	CcSEcCtD
Gliclazide—Asthenia—Triamcinolone—psoriatic arthritis	0.000248	0.000894	CcSEcCtD
Gliclazide—Abdominal pain—Betamethasone—psoriatic arthritis	0.000248	0.000894	CcSEcCtD
Gliclazide—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000248	0.000894	CcSEcCtD
Gliclazide—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000248	0.000894	CcSEcCtD
Gliclazide—Body temperature increased—Betamethasone—psoriatic arthritis	0.000248	0.000894	CcSEcCtD
Gliclazide—Asthenia—Methylprednisolone—psoriatic arthritis	0.000247	0.000892	CcSEcCtD
Gliclazide—Insomnia—Prednisone—psoriatic arthritis	0.000247	0.00089	CcSEcCtD
Gliclazide—Paraesthesia—Prednisone—psoriatic arthritis	0.000245	0.000884	CcSEcCtD
Gliclazide—Pruritus—Triamcinolone—psoriatic arthritis	0.000245	0.000881	CcSEcCtD
Gliclazide—Cough—Methotrexate—psoriatic arthritis	0.000244	0.00088	CcSEcCtD
Gliclazide—Pruritus—Methylprednisolone—psoriatic arthritis	0.000244	0.000879	CcSEcCtD
Gliclazide—Convulsion—Methotrexate—psoriatic arthritis	0.000242	0.000873	CcSEcCtD
Gliclazide—Dyspepsia—Prednisone—psoriatic arthritis	0.00024	0.000866	CcSEcCtD
Gliclazide—Myalgia—Methotrexate—psoriatic arthritis	0.000238	0.000858	CcSEcCtD
Gliclazide—Chest pain—Methotrexate—psoriatic arthritis	0.000238	0.000858	CcSEcCtD
Gliclazide—Arthralgia—Methotrexate—psoriatic arthritis	0.000238	0.000858	CcSEcCtD
Gliclazide—Rash—Prednisolone—psoriatic arthritis	0.000237	0.000854	CcSEcCtD
Gliclazide—Dermatitis—Prednisolone—psoriatic arthritis	0.000237	0.000853	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000237	0.000852	CcSEcCtD
Gliclazide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000236	0.00085	CcSEcCtD
Gliclazide—Fatigue—Prednisone—psoriatic arthritis	0.000236	0.000849	CcSEcCtD
Gliclazide—Headache—Prednisolone—psoriatic arthritis	0.000236	0.000849	CcSEcCtD
Gliclazide—Discomfort—Methotrexate—psoriatic arthritis	0.000235	0.000848	CcSEcCtD
Gliclazide—Constipation—Prednisone—psoriatic arthritis	0.000234	0.000842	CcSEcCtD
Gliclazide—Confusional state—Methotrexate—psoriatic arthritis	0.00023	0.000829	CcSEcCtD
Gliclazide—Dizziness—Triamcinolone—psoriatic arthritis	0.000229	0.000824	CcSEcCtD
Gliclazide—Dizziness—Methylprednisolone—psoriatic arthritis	0.000228	0.000822	CcSEcCtD
Gliclazide—Infection—Methotrexate—psoriatic arthritis	0.000227	0.000817	CcSEcCtD
Gliclazide—Feeling abnormal—Prednisone—psoriatic arthritis	0.000225	0.000811	CcSEcCtD
Gliclazide—Asthenia—Betamethasone—psoriatic arthritis	0.000225	0.000811	CcSEcCtD
Gliclazide—Asthenia—Dexamethasone—psoriatic arthritis	0.000225	0.000811	CcSEcCtD
Gliclazide—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000224	0.000807	CcSEcCtD
Gliclazide—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000224	0.000805	CcSEcCtD
Gliclazide—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000223	0.000805	CcSEcCtD
Gliclazide—Nausea—Prednisolone—psoriatic arthritis	0.000223	0.000805	CcSEcCtD
Gliclazide—Pruritus—Dexamethasone—psoriatic arthritis	0.000222	0.0008	CcSEcCtD
Gliclazide—Pruritus—Betamethasone—psoriatic arthritis	0.000222	0.0008	CcSEcCtD
Gliclazide—Skin disorder—Methotrexate—psoriatic arthritis	0.000222	0.000799	CcSEcCtD
Gliclazide—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000221	0.000795	CcSEcCtD
Gliclazide—Vomiting—Triamcinolone—psoriatic arthritis	0.00022	0.000792	CcSEcCtD
Gliclazide—Vomiting—Methylprednisolone—psoriatic arthritis	0.000219	0.00079	CcSEcCtD
Gliclazide—Rash—Triamcinolone—psoriatic arthritis	0.000218	0.000785	CcSEcCtD
Gliclazide—Dermatitis—Triamcinolone—psoriatic arthritis	0.000218	0.000785	CcSEcCtD
Gliclazide—Rash—Methylprednisolone—psoriatic arthritis	0.000217	0.000784	CcSEcCtD
Gliclazide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000217	0.000783	CcSEcCtD
Gliclazide—Urticaria—Prednisone—psoriatic arthritis	0.000217	0.000782	CcSEcCtD
Gliclazide—Headache—Triamcinolone—psoriatic arthritis	0.000217	0.00078	CcSEcCtD
Gliclazide—Headache—Methylprednisolone—psoriatic arthritis	0.000216	0.000779	CcSEcCtD
Gliclazide—Body temperature increased—Prednisone—psoriatic arthritis	0.000216	0.000778	CcSEcCtD
Gliclazide—Abdominal pain—Prednisone—psoriatic arthritis	0.000216	0.000778	CcSEcCtD
Gliclazide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000215	0.000773	CcSEcCtD
Gliclazide—Diarrhoea—Betamethasone—psoriatic arthritis	0.000215	0.000773	CcSEcCtD
Gliclazide—Hypotension—Methotrexate—psoriatic arthritis	0.000213	0.000769	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000208	0.00075	CcSEcCtD
Gliclazide—Dizziness—Betamethasone—psoriatic arthritis	0.000207	0.000747	CcSEcCtD
Gliclazide—Dizziness—Dexamethasone—psoriatic arthritis	0.000207	0.000747	CcSEcCtD
Gliclazide—Insomnia—Methotrexate—psoriatic arthritis	0.000206	0.000744	CcSEcCtD
Gliclazide—Nausea—Triamcinolone—psoriatic arthritis	0.000205	0.00074	CcSEcCtD
Gliclazide—Paraesthesia—Methotrexate—psoriatic arthritis	0.000205	0.000739	CcSEcCtD
Gliclazide—Nausea—Methylprednisolone—psoriatic arthritis	0.000205	0.000738	CcSEcCtD
Gliclazide—Dyspnoea—Methotrexate—psoriatic arthritis	0.000204	0.000733	CcSEcCtD
Gliclazide—Somnolence—Methotrexate—psoriatic arthritis	0.000203	0.000731	CcSEcCtD
Gliclazide—Hypersensitivity—Prednisone—psoriatic arthritis	0.000201	0.000725	CcSEcCtD
Gliclazide—Dyspepsia—Methotrexate—psoriatic arthritis	0.000201	0.000724	CcSEcCtD
Gliclazide—Vomiting—Betamethasone—psoriatic arthritis	0.000199	0.000719	CcSEcCtD
Gliclazide—Vomiting—Dexamethasone—psoriatic arthritis	0.000199	0.000719	CcSEcCtD
Gliclazide—Rash—Dexamethasone—psoriatic arthritis	0.000198	0.000713	CcSEcCtD
Gliclazide—Rash—Betamethasone—psoriatic arthritis	0.000198	0.000713	CcSEcCtD
Gliclazide—Dermatitis—Dexamethasone—psoriatic arthritis	0.000198	0.000712	CcSEcCtD
Gliclazide—Dermatitis—Betamethasone—psoriatic arthritis	0.000198	0.000712	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000197	0.00071	CcSEcCtD
Gliclazide—Fatigue—Methotrexate—psoriatic arthritis	0.000197	0.000709	CcSEcCtD
Gliclazide—Headache—Betamethasone—psoriatic arthritis	0.000197	0.000708	CcSEcCtD
Gliclazide—Headache—Dexamethasone—psoriatic arthritis	0.000197	0.000708	CcSEcCtD
Gliclazide—Asthenia—Prednisone—psoriatic arthritis	0.000196	0.000706	CcSEcCtD
Gliclazide—Pain—Methotrexate—psoriatic arthritis	0.000195	0.000703	CcSEcCtD
Gliclazide—Pruritus—Prednisone—psoriatic arthritis	0.000193	0.000696	CcSEcCtD
Gliclazide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000188	0.000678	CcSEcCtD
Gliclazide—Diarrhoea—Prednisone—psoriatic arthritis	0.000187	0.000674	CcSEcCtD
Gliclazide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000187	0.000673	CcSEcCtD
Gliclazide—Nausea—Betamethasone—psoriatic arthritis	0.000186	0.000671	CcSEcCtD
Gliclazide—Nausea—Dexamethasone—psoriatic arthritis	0.000186	0.000671	CcSEcCtD
Gliclazide—Urticaria—Methotrexate—psoriatic arthritis	0.000181	0.000654	CcSEcCtD
Gliclazide—Dizziness—Prednisone—psoriatic arthritis	0.000181	0.000651	CcSEcCtD
Gliclazide—Abdominal pain—Methotrexate—psoriatic arthritis	0.00018	0.00065	CcSEcCtD
Gliclazide—Body temperature increased—Methotrexate—psoriatic arthritis	0.00018	0.00065	CcSEcCtD
Gliclazide—Vomiting—Prednisone—psoriatic arthritis	0.000174	0.000626	CcSEcCtD
Gliclazide—Rash—Prednisone—psoriatic arthritis	0.000172	0.000621	CcSEcCtD
Gliclazide—Dermatitis—Prednisone—psoriatic arthritis	0.000172	0.00062	CcSEcCtD
Gliclazide—Headache—Prednisone—psoriatic arthritis	0.000171	0.000617	CcSEcCtD
Gliclazide—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000168	0.000606	CcSEcCtD
Gliclazide—Asthenia—Methotrexate—psoriatic arthritis	0.000164	0.00059	CcSEcCtD
Gliclazide—Nausea—Prednisone—psoriatic arthritis	0.000162	0.000585	CcSEcCtD
Gliclazide—Pruritus—Methotrexate—psoriatic arthritis	0.000162	0.000582	CcSEcCtD
Gliclazide—Diarrhoea—Methotrexate—psoriatic arthritis	0.000156	0.000563	CcSEcCtD
Gliclazide—Dizziness—Methotrexate—psoriatic arthritis	0.000151	0.000544	CcSEcCtD
Gliclazide—Vomiting—Methotrexate—psoriatic arthritis	0.000145	0.000523	CcSEcCtD
Gliclazide—Rash—Methotrexate—psoriatic arthritis	0.000144	0.000519	CcSEcCtD
Gliclazide—Dermatitis—Methotrexate—psoriatic arthritis	0.000144	0.000518	CcSEcCtD
Gliclazide—Headache—Methotrexate—psoriatic arthritis	0.000143	0.000515	CcSEcCtD
Gliclazide—Nausea—Methotrexate—psoriatic arthritis	0.000136	0.000489	CcSEcCtD
